59 results
8-K
EX-10.1
XERS
Xeris Pharmaceuticals Inc
5 Oct 21
Entry into a Material Definitive Agreement
4:15pm
8-K
EX-10.1
n5xs7626q25on0bzfv6c
29 Jul 21
Xeris Pharmaceuticals Announces Executive Changes As Part of Its Strategy to Position the Company for Long-term Commercial Success
12:00am
8-K
EX-10.2
hqgud
29 Jul 21
Xeris Pharmaceuticals Announces Executive Changes As Part of Its Strategy to Position the Company for Long-term Commercial Success
12:00am
8-K
EX-10.3
jtw1lq9
24 May 21
This Announcement Is Being Made Pursuant to Rule 2.5 of the Irish Takeover Rules
7:11am
8-K
EX-10.1
j6lo27s5gocfsi5ssd
24 May 21
This Announcement Is Being Made Pursuant to Rule 2.5 of the Irish Takeover Rules
7:11am
8-K
EX-10.2
39hs1h4jk74z9 gg1e0
24 May 21
This Announcement Is Being Made Pursuant to Rule 2.5 of the Irish Takeover Rules
7:11am
8-K
EX-10.4
xmcvh
24 May 21
This Announcement Is Being Made Pursuant to Rule 2.5 of the Irish Takeover Rules
7:11am
8-K
EX-10.1
mjlq2i2e4b768uxrzn
11 Mar 21
Xeris Pharmaceuticals Announces Pricing of $27.0 Million
7:09am
8-K
EX-10.1
hvw6i6o a7
16 Nov 20
Unregistered Sales of Equity Securities
7:26am